Period End Date | 2021-12-31 | 2020-12-31 | 2019-12-31 | 0000-00-00 | 0000-00-00 |
Total Revenue | 600,428,000.00 | 281,374,000.00 | 219,682,000.00 | -- | -- |
Cost of Revenue, Total | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
Operating Income | -292,325,000.00 | -275,791,000.00 | -328,472,000.00 | -- | -- |
Total Premiums Earned | -- | -- | -- | -- | -- |
Net Investment Income | -- | -- | -- | -- | -- |
Updated at 22:47:38 | -- | -- | -- | -- | -- |
Net Interest Income | -- | -- | -- | -- | -- |
Loan Loss Provision | -- | -- | -- | -- | -- |
Net Interest Income After Loan Loss Provision | -- | -- | -- | -- | -- |
Non-Interest Income, Bank | -- | -- | -- | -- | -- |
Total Premiums Earned | -- | -- | -- | -- | -- |
Net Investment Income | -- | -- | -- | -- | -- |
Realized and Unrealized Gains (Losses) | -- | -- | -- | -- | -- |
Other Revenue, Total | -- | -- | -- | -- | -- |
Losses, Benefits, and Adjustments, Total | -- | -- | -- | -- | -- |
Depreciation / Depletion, Cumulative | -- | -- | -- | -- | -- |
Updated at 22:48:08 | -- | -- | -- | -- | -- |
Accumulated Depreciation, Total | -- | -- | -- | -- | -- |
Net Income Before Extraordinary Items | -242,440,000.00 | -238,801,000.00 | -262,880,000.00 | -- | -- |
Normalized Income Before Taxes | -241,522,000.00 | -242,546,000.00 | -262,419,000.00 | -- | -- |
Net Income Before Extraordinary Items | -242,440,000.00 | -238,801,000.00 | -262,880,000.00 | -- | -- |
Net Income Incl Extra Before Distributions | -242,440,000.00 | -238,801,000.00 | -262,880,000.00 | -- | -- |
Income Avail to Cmn Shareholders Excl Extra | -242,440,000.00 | -238,801,000.00 | -262,880,000.00 | -- | -- |
Income Avail to Cmn Shareholders Incl Extra | -242,440,000.00 | -238,801,000.00 | -262,880,000.00 | -- | -- |
Net Income Before Taxes | -242,051,000.00 | -238,354,000.00 | -262,370,000.00 | -- | -- |
Provision for Income Taxes | 389,000.00 | 447,000.00 | 510,000.00 | -- | -- |
Net Income After Taxes | -242,440,000.00 | -238,801,000.00 | -262,880,000.00 | -- | -- |
Updated at 22:48:23 | -- | -- | -- | -- | -- |
Basic Normalized EPS | -1.61 | -2.11 | -2.39 | -- | -- |
Cash and Short Term Investments | 143,773,000.00 | 86,503,000.00 | -- | -- | -- |
Total Assets, Reported | 1,155,388,000.00 | 1,050,172,000.00 | -- | -- | -- |
Total Long Term Debt | 17,723,000.00 | 36,465,000.00 | -- | -- | -- |
Total Debt | 17,723,000.00 | 36,465,000.00 | -- | -- | -- |
Total Liabilities | 846,719,000.00 | 599,303,000.00 | -- | -- | -- |
Total Equity | 308,669,000.00 | 450,869,000.00 | -- | -- | -- |
Total Liabilities And Shareholders' Equity | 1,155,388,000.00 | 1,050,172,000.00 | -- | -- | -- |
Total Common Shares Outstanding | 150,172,010.00 | 150,172,010.00 | -- | -- | -- |
Updated at 22:48:44 | -- | -- | -- | -- | -- |
Cash from Operating Activities, Cumulative | -50,861,000.00 | -185,626,000.00 | -193,514,000.00 | -- | -- |
Net Cash - Beginning Balance | 86,503,000.00 | 112,844,000.00 | 73,881,000.00 | -- | -- |
Net Cash - Ending Balance | 143,773,000.00 | 86,503,000.00 | 112,844,000.00 | -- | -- |
Net Change in Cash, Cumulative | 57,270,000.00 | -26,341,000.00 | 38,963,000.00 | -- | -- |
Net Income/Starting Line, Cumulative | -- | -- | -- | -- | -- |
Capital Expenditures, Cumulative | -3,941,000.00 | -6,989,000.00 | -46,986,000.00 | -- | -- |
Capital Expenditures - Actual | -- | -- | -- | -- | -- |